Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Sona Nanotech Inc
Bullboard Posts
User Avatar Image
(12)
•••
Comment by Wiseeon Mar 28, 2020 11:59am
84 Views
Post# 30855894

RE:Molecular Test Versus Our Next Gen Nanorod Test

RE:Molecular Test Versus Our Next Gen Nanorod TestOk.  let's have an honest debate...

I can pick up a Sona test, keeping my distance from others, that gives a positive or negative result for the actual virus in 5-15 minutes without seeing a Dr or a lab/technical professional. Negative, I go about my day.  Positive, I phone the telehealth phone line and get the next treatment steps lined up.  I'm 10-15 minutes from my pharmacy, I can complete this whole process in an hour or less.

1) How is SONA's product going to get to your pharmacy?  
Mass retail distribution does not happen overnight. 

2) Let's assume that SONA's product is in all the pharmacies in the world. 
How many of us are going to pay $10 to $50 for this test kit out of our own pockets?  
When was the last time you or your parents got any health test done by buying it and doing it at home?  

3) The 5-15 mins SONA test will give you a preliminary yes or no.   You will still need to go and get further tests to confirm.  

Watch the video... at the 46 second mark. 
https://globalnews.ca/video/6652368/tool-being-developed-to-fight-coronavirus

Watch and learn, 

Wisee
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities